Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023

Published on August 24, 2023

This report describes the Advisory Committee on Immunization Practices' recommendation for using nirsevimab for infants and children to prevent severe respiratory syncytial virus disease.